本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Sol-Gel Technologies

0.5850
+0.03506.36%
盘后0.5728-0.0122-2.09%18:26 EDT
成交量:107.29万
成交额:72.10万
市值:1,629.67万
市盈率:-1.68
高:0.7991
开:0.5400
低:0.5102
收:0.5500
数据加载中...

公司资料

公司名字:
Sol-Gel Technologies
交易所:
NASDAQ
成立时间:
1997
员工人数:
36
公司地址:
7 Golda Meir Street,Weizmann Science Park,Ness Ziona,Israel
邮编:
7403650
传真:
- -
简介:
Sol-gel Technologies Ltd.1997年10月28日根据以色列国法律注册成立。该公司是一家创新型皮肤病学公司,拥有两项NDA批准的成功记录,以及正在为孤儿适应症开发的先进候选产品管道。Sol-Gel成功研发开创性外用药物Twyneo和Epsolay,分别获批用于红斑痤疮和炎症性病变的治疗。

董事

名称
职位
Alon Seri Levy
Chief Executive Officer and Director
Moshe Arkin
Chairman of the Board
Jerrold S. Gattegno
External Director
Ran Gottfried
External Director
Hani Lerman
Director
Itai Arkin
Director
Jonathan B. Siegel
Director
Shmuel Ben Zvi
Director
Yaffa Krindel Sieradzki
Director

股东

名称
职位
Alon Seri Levy
Chief Executive Officer and Director
Gilad Mamlok
Chief Financial Officer
Dov Zamir
Vice President Special Projects
Itzik Yosef
Vice President Operations
John Vieira
U.S. Head of Commercialization
Karine Neimann
Vice President Projects and Planning, Chief Chemist
Nissim Bilman
Vice President Quality
Ofer Toledano
Vice President Research and Development
Ofra Levy Hacham
Vice President Clinical and Regulatory Affairs